Sunshine Biopharma Inc. Lessee, Operating Lease, Liability, to be Paid, Year One
Sunshine Biopharma Inc. (SBFM) had Lessee, Operating Lease, Liability, to be Paid, Year One of $197.18 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-08-13
- 2026-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $197.18K.
- 2026-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $201.01K.
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $215.64K.
- 2025-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $212.31K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One | Lessee, Operating Lease, Liability, to be Paid, Year One as first filed |
|---|---|---|
| 2026-06-30 | $197.18K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $201.01K 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $215.64K 10-K · filed 2026-04-03 | |
| 2025-09-30 | $212.31K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $216.63K 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $205.59K 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $207.76K 10-K · filed 2025-04-01 | |
| 2024-09-30 | $116.46K 10-Q · filed 2024-11-05 | |
| 2024-06-30 | $114.86K 10-Q/A · filed 2024-08-20 | |
| 2024-03-31 | $116.02K 10-Q · filed 2024-05-20 | |
| 2023-09-30 | $116.09K 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $118.55K 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $91.65K 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $118.67K 10-K · filed 2024-03-28 | $123.03K 10-K · filed 2023-04-04 |
| 2019-03-31 | $35.22K 10-Q · filed 2019-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |